Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer.
暂无分享,去创建一个
D Andrew Loblaw | Jean-Philippe Pignol | Patrick Cheung | Gerard Morton | K. Sixel | R. Tirona | P. Cheung | J. Pignol | E. Szumacher | G. Deboer | R. Choo | G. Morton | D. Loblaw | G. Pang | Romeo Tirona | Richard Choo | Gerrit Deboer | Ewa Szumacher | Katharina Sixel | Geordi Pang
[1] J. Wong,et al. Flat-panel cone-beam computed tomography for image-guided radiation therapy. , 2002, International journal of radiation oncology, biology, physics.
[2] Jian Z. Wang,et al. The low α/β ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us? , 2003 .
[3] W. J. Morris,et al. Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] V. Khoo,et al. Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis. , 2002, International journal of radiation oncology, biology, physics.
[5] C. Catton,et al. Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and urethrography. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] J. Tsai,et al. Implementation and utility of a daily ultrasound-based localization system with intensity-modulated radiotherapy for prostate cancer. , 2002, International journal of radiation oncology, biology, physics.
[7] H Alasti,et al. Portal imaging for evaluation of daily on-line setup errors and off-line organ motion during conformal irradiation of carcinoma of the prostate. , 2001, International journal of radiation oncology, biology, physics.
[8] Patrick A Kupelian,et al. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. , 2002, International journal of radiation oncology, biology, physics.
[9] J M Balter,et al. A comparison of ventilatory prostate movement in four treatment positions. , 2000, International journal of radiation oncology, biology, physics.
[10] J. Fowler,et al. Image guidance for precise conformal radiotherapy. , 2003, International journal of radiation oncology, biology, physics.
[11] D. Kuban,et al. Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. , 2003, International journal of radiation oncology, biology, physics.
[12] A Pollack,et al. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. , 2000, International journal of radiation oncology, biology, physics.
[13] H. Kal,et al. HOW LOW IS THE / RATIO FOR PROSTATE CANCER? , 2003 .
[14] Michael J. Zelefsky,et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. , 2002, International journal of radiation oncology, biology, physics.
[15] Lei Dong,et al. Intrafraction prostate motion during IMRT for prostate cancer. , 2001, International journal of radiation oncology, biology, physics.
[16] T Haycocks,et al. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] Wilfred Sewchand,et al. Marker seed migration in prostate localization. , 2003, International journal of radiation oncology, biology, physics.
[18] D P Dearnaley,et al. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. , 1999, International journal of radiation oncology, biology, physics.
[19] C. Ling,et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. , 2000, International journal of radiation oncology, biology, physics.
[20] C. Catton,et al. Clinical and biochemical outcome of conventional dose radiotherapy for localized prostate cancer. , 2002, The Canadian journal of urology.
[21] George Starkschall,et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. , 2002, International journal of radiation oncology, biology, physics.
[22] David A Jaffray,et al. Online ultrasound image guidance for radiotherapy of prostate cancer: impact of image acquisition on prostate displacement. , 2004, International journal of radiation oncology, biology, physics.
[23] Richard K Valicenti,et al. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV. , 2004, International journal of radiation oncology, biology, physics.
[24] D. Kuban,et al. High-dose intensity modulated radiation therapy for prostate cancer , 2004, Current urology reports.
[25] J Pouliot,et al. Robustness and precision of an automatic marker detection algorithm for online prostate daily targeting using a standard V-EPID. , 2003, Medical physics.
[26] T E Schultheiss,et al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. , 1998, International journal of radiation oncology, biology, physics.
[27] J. Pouliot,et al. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. , 2003, International journal of radiation oncology, biology, physics.
[28] C C Ling,et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. , 2001, The Journal of urology.
[29] E. B. Butler,et al. Predictors of Extracapsular Extension and Its Radial Distance in Prostate Cancer: Implications for Prostate IMRT, Brachytherapy, and Surgery , 2003, Cancer journal.
[30] H. Hricak,et al. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. , 1996, International journal of radiation oncology, biology, physics.
[31] Jean Pouliot,et al. (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device. , 2003, International journal of radiation oncology, biology, physics.
[32] J H Hendry,et al. Hypofractionation for prostate cancer. , 2001, International journal of radiation oncology, biology, physics.
[33] Gary A Ezzell,et al. Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy. , 2001, International journal of radiation oncology, biology, physics.
[34] Shinichi Shimizu,et al. Three-dimensional intrafractional movement of prostate measured during real-time tumor-tracking radiotherapy in supine and prone treatment positions. , 2002, International journal of radiation oncology, biology, physics.
[35] W Cavanagh,et al. Comparability of CT-based and TRUS-based prostate volumes. , 1999, International journal of radiation oncology, biology, physics.
[36] T R Willoughby,et al. Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland. , 2000, International journal of radiation oncology, biology, physics.
[37] S. Hancock,et al. Control of prostate cancer with radiotherapy: long-term results. , 1994, The Journal of urology.
[38] Franca Foppiano,et al. Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer. , 2003, International journal of radiation oncology, biology, physics.
[39] D. Brenner,et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue , 2002 .
[40] William R. Fair,et al. DOSE ESCALATION WITH THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AFFECTS THE OUTCOME IN PROSTATE CANCER , 1998 .
[41] Jan J W Lagendijk,et al. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[42] Arthur Hung,et al. A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancer. , 2003, International journal of radiation oncology, biology, physics.
[43] R. Bristow,et al. Hypofractionated intensity modulated radiation therapy for prostate cancer , 2002 .
[44] J Szanto,et al. Respiratory-induced prostate motion: quantification and characterization. , 2000, International journal of radiation oncology, biology, physics.
[45] E. B. Butler,et al. IMRT for prostate cancer: defining target volume based on correlated pathologic volume of disease. , 2003, International journal of radiation oncology, biology, physics.
[46] Lei Dong,et al. Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: implications for treatment margins. , 2003, International journal of radiation oncology, biology, physics.
[47] T. Pajak,et al. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.
[48] D J Brenner,et al. Fractionation and protraction for radiotherapy of prostate carcinoma. , 1999, International journal of radiation oncology, biology, physics.
[49] J Pouliot,et al. Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. , 1997, International journal of radiation oncology, biology, physics.
[50] Rick Chappell,et al. Is α/β for prostate tumors really low? , 2001 .
[51] Frieda Trichter,et al. Prostate localization using transabdominal ultrasound imaging. , 2003, International journal of radiation oncology, biology, physics.
[52] R. Fraser,et al. Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial. , 2003, International journal of radiation oncology, biology, physics.
[53] A. Markoe,et al. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy). , 2002, International journal of radiation oncology, biology, physics.
[54] P L Roberson,et al. Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants. , 1997, International journal of radiation oncology, biology, physics.
[55] Jian Z. Wang,et al. Low α/β ratio for prostate cancer: in response to Dr. Fowler et al. , 2003 .
[56] L Souhami,et al. Controversies in prostate cancer radiotherapy: consensus development. , 2001, The Canadian journal of urology.
[57] G J Kutcher,et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. , 2001, International journal of radiation oncology, biology, physics.
[58] A. Zietman,et al. The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome. , 1995, International journal of radiation oncology, biology, physics.
[59] T. Mate,et al. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. , 2004, International journal of radiation oncology, biology, physics.
[60] J C Stroom,et al. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability. , 1999, International journal of radiation oncology, biology, physics.
[61] A. Swan,et al. Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique. , 1991, Clinical oncology (Royal College of Radiologists (Great Britain)).
[62] D. Kuban,et al. Hazards of dose escalation in prostate cancer radiotherapy. , 2003, International journal of radiation oncology, biology, physics.
[63] A. Pollack,et al. External beam radiotherapy dose response of prostate cancer. , 1997, International journal of radiation oncology, biology, physics.
[64] Michael G Herman,et al. Technical aspects of daily online positioning of the prostate for three-dimensional conformal radiotherapy using an electronic portal imaging device. , 2003, International journal of radiation oncology, biology, physics.
[65] M van Herk,et al. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. , 1995, International journal of radiation oncology, biology, physics.
[66] Mark Ruschin,et al. Integration of digital fluoroscopy with CT-based radiation therapy planning of lung tumors. , 2002, Medical physics.
[67] J. Corman,et al. Intrafractional stability of the prostate using a stereotactic radiotherapy technique , 2003 .
[68] W. Curran,et al. Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. , 2000, International journal of radiation oncology, biology, physics.
[69] J. Rowlands,et al. Electronic portal imaging with an avalanche-multiplication-based video camera. , 2000, Medical physics.
[70] X. Allen Li,et al. HOW LOW IS THE / RATIO FOR PROSTATE CANCER? , 2003 .